Xavier Bresse

530 total citations
28 papers, 426 citations indexed

About

Xavier Bresse is a scholar working on Epidemiology, Surgery and Health. According to data from OpenAlex, Xavier Bresse has authored 28 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 6 papers in Surgery and 5 papers in Health. Recurrent topics in Xavier Bresse's work include Cervical Cancer and HPV Research (11 papers), Pneumonia and Respiratory Infections (7 papers) and Hepatitis B Virus Studies (6 papers). Xavier Bresse is often cited by papers focused on Cervical Cancer and HPV Research (11 papers), Pneumonia and Respiratory Infections (7 papers) and Hepatitis B Virus Studies (6 papers). Xavier Bresse collaborates with scholars based in France, Belgium and Germany. Xavier Bresse's co-authors include Nathalie Largeron, Lieven Annemans, Aline Gauthier, Yiling Jiang, Stéphane Roze, Jayne Smith‐Palmer, Jürgen Wasem, Pierre Lévy, Elmar A. Joura and Mark van der Linden and has published in prestigious journals such as PLoS ONE, Vaccine and BMC Cancer.

In The Last Decade

Xavier Bresse

26 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Bresse France 14 346 96 75 51 50 28 426
Kurt Banz Germany 13 266 0.8× 35 0.4× 33 0.4× 21 0.4× 65 1.3× 30 431
Hilde Vroling United States 12 397 1.1× 31 0.3× 28 0.4× 35 0.7× 71 1.4× 17 520
Robert Samuel United Kingdom 8 330 1.0× 84 0.9× 39 0.5× 28 0.5× 10 0.2× 15 467
Nicole Harrison Austria 12 180 0.5× 75 0.8× 59 0.8× 50 1.0× 31 0.6× 37 442
Benedetto Simone Italy 10 134 0.4× 80 0.8× 22 0.3× 21 0.4× 16 0.3× 30 282
Nirma Khatri Vadlamudi Canada 10 306 0.9× 26 0.3× 12 0.2× 9 0.2× 51 1.0× 27 419
Goran Benčina Spain 10 173 0.5× 50 0.5× 11 0.1× 68 1.3× 12 0.2× 60 290
Freddy Caldera United States 15 262 0.8× 130 1.4× 40 0.5× 51 1.0× 47 0.9× 89 617
Airi Põder Estonia 9 360 1.0× 36 0.4× 111 1.5× 14 0.3× 5 0.1× 23 588
B Ndlela Zimbabwe 6 347 1.0× 60 0.6× 98 1.3× 106 2.1× 51 1.0× 10 508

Countries citing papers authored by Xavier Bresse

Since Specialization
Citations

This map shows the geographic impact of Xavier Bresse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Bresse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Bresse more than expected).

Fields of papers citing papers by Xavier Bresse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Bresse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Bresse. The network helps show where Xavier Bresse may publish in the future.

Co-authorship network of co-authors of Xavier Bresse

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Bresse. A scholar is included among the top collaborators of Xavier Bresse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Bresse. Xavier Bresse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rycke, Yann De, Florence Tubach, Alexandre Lafourcade, et al.. (2020). Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France. PLoS ONE. 15(2). e0228660–e0228660. 10 indexed citations
2.
Abramowitz, Laurent, Jean Lacau Saint Guily, Micheline Moyal‐Barracco, et al.. (2018). Epidemiological and economic burden of potentially HPV-related cancers in France. PLoS ONE. 13(9). e0202564–e0202564. 17 indexed citations
3.
Dervaux, B., Sophie Dubois, Anne Josseran, et al.. (2017). What is the budget impact of a new treatment or new health technology arriving on the market?. Therapies. 72(1). 93–103. 2 indexed citations
4.
Abramowitz, Laurent, M. Moyal‐Barracco, Nathalie Largeron, et al.. (2016). Epidemiology, Treatment Pathways and Costs of Cancers Potentially Related to HPV Infection in France. Value in Health. 19(7). A609–A610. 1 indexed citations
5.
Jiang, Yiling, et al.. (2015). A comparative public health and budget impact analysis of pneumococcal vaccines: The French case. Human Vaccines & Immunotherapeutics. 11(9). 2188–2197. 8 indexed citations
6.
Uhart, M., et al.. (2015). Loss Of Opportunity Linked With The Suboptimal Coverage Rate Of Hpv Vaccination In France. Value in Health. 18(7). A462–A462. 1 indexed citations
7.
Bresse, Xavier, et al.. (2014). A macro Economic Analysis of 65 Year-Old 'Rendez-vous Vaccinal 'in France: What is the Return on Investment?. Value in Health. 17(7). A680–A680. 1 indexed citations
8.
Jiang, Yiling, et al.. (2014). A comparative public health and budget impact analysis of pneumococcal vaccines. The french case. Value in Health. 17(7). A668–A668. 1 indexed citations
9.
Marsh, Kevin, Ruth Chapman, Rebecca F. Baggaley, Nathalie Largeron, & Xavier Bresse. (2014). Mind the gaps: What's missing from current economic evaluations of universal HPV vaccination?. Vaccine. 32(30). 3732–3739. 18 indexed citations
10.
Bresse, Xavier, et al.. (2014). Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost–effectiveness analysis. Expert Review of Pharmacoeconomics & Outcomes Research. 14(2). 269–281. 33 indexed citations
11.
Jiang, Yiling, Aline Gauthier, Maarten J. Postma, et al.. (2013). A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus. Human Vaccines & Immunotherapeutics. 9(11). 2285–2295. 26 indexed citations
12.
Bresse, Xavier, et al.. (2013). Vaccination against herpes zoster and postherpetic neuralgia in France: a cost–effectiveness analysis. Expert Review of Pharmacoeconomics & Outcomes Research. 13(3). 393–406. 35 indexed citations
13.
Roze, Stéphane, et al.. (2013). Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe. BMC Cancer. 13(1). 10–10. 65 indexed citations
14.
Bresse, Xavier, et al.. (2012). PIN63 Vaccination Against Herpes Zoster and Post-Herpetic Neuralgia in France: A Cost-Effectiveness Analysis. Value in Health. 15(7). A396–A396. 1 indexed citations
15.
Jiang, Yiling, et al.. (2012). Cost–effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Germany. Expert Review of Pharmacoeconomics & Outcomes Research. 12(5). 645–660. 24 indexed citations
16.
Jiang, Yiling & Xavier Bresse. (2012). Expert Review of Pharmacoeconomics & Outcomes Research. 8 indexed citations
17.
Jiang, Yiling, et al.. (2012). A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany. Expert Review of Pharmacoeconomics & Outcomes Research. 12(5). 631–643. 14 indexed citations
18.
Jiang, Yiling, et al.. (2011). PIN74 A Cost-Effectiveness Analysis of Vaccinating the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Germany. Value in Health. 14(7). A279–A279. 1 indexed citations
19.
Szucs, Thomas D., et al.. (2011). Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland. Human Vaccines. 7(7). 749–756. 32 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kurt Banz Breakdown of academic impact, for papers by Hilde Vroling Breakdown of academic impact, for papers by Robert Samuel Breakdown of academic impact, for papers by Nicole Harrison Breakdown of academic impact, for papers by Benedetto Simone Breakdown of academic impact, for papers by Nirma Khatri Vadlamudi Breakdown of academic impact, for papers by Goran Benčina Breakdown of academic impact, for papers by Freddy Caldera Breakdown of academic impact, for papers by Airi Põder Breakdown of academic impact, for papers by B Ndlela
Rankless by CCL
2026